Klaria Pharma
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Klaria Interim Report Q3 2024
Third quarter of 2024
The group in total
- Net sales 0.0 MSEK (0.6 MSEK)
- Other income 0.0 MSEK (0.0 MSEK)
- R&D expenses for the quarter amounted to 1 MSEK (7.4 MSEK)
- Profit after tax amounted to -7.9 MSEK (-10.8 MSEK)
- Earnings per share for the quarter amounted to -0.06 SEK (-0.10 SEK)
- Cash flow from operating activities amounted to -3.8 MSEK (-7.3 MSEK)
- Liquid assets on the balance sheet date amounted to 0.5 MSEK (2.3 MSEK)
- Equity as of September 30 amounted to 12.9 MSEK (50.7 MSEK)
The period January- September 2024
The group in total
- Net sales 0.0 MSEK (7.1 MSEK)
- Other income 0.0 MSEK (0.2 MSEK)
- R&D expenses for the quarter amounted to 2.5 MSEK (23.0 MSEK)
- Profit after tax amounted to -32.2 MSEK (-26.3 MSEK)
- Earnings per share for the period amounted to -0.26 SEK (-0.27 SEK)
- Cash flow from operating activities amounted to -13.2 MSEK (-18.6 MSEK)
| Datum | 2024-11-21, kl 15:00 |
| Källa | Cision |